Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study

Clinics

Volumn 70, Issue 8, 2015, Pages 563-568

  Xiong, Ji ^a   Wang, Jun ^a,b   Huang, Juan ^a   Sun, Wenjing ^a   Chen, Dongfeng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Medical Team of Chinese People s Armed Police Force   (China)

Author keywords

Liver cirrhosis; Metabolism; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Obesity

Indexed keywords

ADULT; AGE; AGED; BODY MASS; CARCINOMA, HEPATOCELLULAR; CHINA; COMPLICATION; DIABETES MELLITUS; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOGENICITY; SEX DIFFERENCE; TIME FACTOR;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; CHINA; DIABETES COMPLICATIONS; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; SEX FACTORS; TIME FACTORS;

EID: 84938788526     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2015(08)06     Document Type: Article

References (33)

1. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550-7, http://dx.doi.org/10.1016/j.vaccine.2009.08.048.
2. Schutte K, Kipper M, Kahl S, Bornschein J, Gotze T, Adolf D, et al. Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany. Digestion. 2013;87(3):147-59, http://dx.doi.org/10.1159/000346743.
3. Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol. 2010;41(3):425-30, http://dx.doi.org/10.1016/j.humpath.2009.06.021.
4. Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45(1):86-94, http://dx.doi.org/10.1007/s00535-009-0128-5.
5. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838-51 http://dx.doi.org/10.1016/S0140-6736(08)60383-9.
6. Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: A general population-based study. J Hepatol. 2008;49(5):732-8, http://dx.doi.org/10.1016/j.jhep.2008.05.023.
7. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-38, http://dx.doi.org/10.1016/j.jhep.2006.05.013.
8. Huang P, Zhu LG, Zhai XJ, Zhu YF, Yue M, Su J, et al. Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012. Epidemiol Infect. 2015;Jan 20:1-10.
9. Qing Wang, Lianyou Hu, Daihong Zhao, Sun M. Seroepidemiological Survey and Analysis of Virus Hepatitis C in Chongqing. J Prev Med Inf. 2007;23(2):152-4.
10. Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, et al. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. Journal of Epidemiology. 2011;21(6):401-16, http://dx.doi.org/10.2188/jea.JE20100190.
11. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006; 43(2 Suppl 1):S173-81.
12. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009;200(1):39-47, http://dx.doi.org/10.1086/599173.
13. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol. 2013;10(11):656-65, http://dx.doi.org/10.1038/nrgastro.2013.183.
14. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34(3):274-85, http://dx.doi.org/10.1111/apt.2011.34.issue-3.
15. Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2013;28 Suppl 1:11-7.
16. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50(1):204-10, http://dx.doi.org/10.1016/j.jhep.2008.10.010.
17. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AMS. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127(5):S97-S103, http://dx.doi.org/10.1053/j.gastro.2004.09.021.
18. Karagozian R, Derdak Z, Baffy G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism. 2014.
19. Mena A, Pedreira JD, Castro A, Lopez S, Vazquez P, Poveda E. Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. J Gastroenterol Hepatol. 2014;29(1):173-8, http://dx.doi.org/10.1111/jgh.2014.29.issue-1.
20. Kristi R DG, Paul KW,Xigui Wu. Prevalence and risk factors of overweight and obesity in China. Brief Epidemiologic Report. 2007;15(1):10-8.
21. CM C. Overview of obesity in Mainland China. Obesity reviews. 2008; 9(suppl 1):14-21.
22. Dongdong Liu WL, Gongshu Liu. Survey on obesity of 24343 children under 7 years old in Tianjing. Zhong Guo Fu You Bao Jian. 2013; 28(22):3646-7.
23. Corey KE, Kaplan LM. Obesity and liver disease: the epidemic of the twenty-first century. Clin Liver Dis. 2014;18(1):1-18, http://dx.doi.org/10.1016/j.cld.2013.09.019.
24. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51(6):1972-8, http://dx.doi.org/10.1002/hep.23527.
25. Jing Gao CW, Li Xie, Pingping Bao. Incidence and mortality of primary liver cancer in Shanghai, 2006-2008. Tumor. 2012;32(7):526-30.
26. Chen CT, Chen JY, Wang JH, Chang KC, Tseng PL, Kee KM, et al. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV-and HCV-endemic area of Southern Taiwan. Kaohsiung J Med Sci. 2013;29(8):451-9, http://dx.doi.org/10.1016/j.kjms.2012.12.006.
27. Kawada N, Imanaka K, Kawaguchi T, Tamai C, Ishihara R, Matsunaga T, et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol. 2009;44(12):1190-4, http://dx.doi.org/10.1007/s00535-009-0112-0.
28. Yasui K, Hashimoto E, Tokushige K, Koike K, Shima T, Kanbara Y, et al. Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma. Hepatol Res. 2012;42(8):767-73, http://dx.doi.org/10.1111/hepr.2012.42.issue-8.
29. Berentzen TL, Gamborg M, Holst C, Sorensen TI, Baker JL. Body mass index in childhood and adult risk of primary liver cancer. J Hepatol. 2014;60(2):325-30, http://dx.doi.org/10.1016/j.jhep.2013.09.015.
30. Jessica Dyson BJ, Dipankar Chattopadyhay, Rajiv Lochan, Janine Graham, Debasish Das. Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team. Journal of hepatology. 2014;60:110-7, http://dx.doi.org/10.1016/j.jhep.2013.08.011.
31. Rodrigues MH, Bruno AS, Nahas-Neto J, Santos ME, Nahas EA. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. Gynecol Endocrinol. 2014;30(5):325-9, http://dx.doi.org/10.3109/09513590.2013.875992.
32. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol. 2012;18(3):237-43, http://dx.doi.org/10.3748/wjg.v18.i3.237.
33. Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res. 2007;37(4):239-47, http://dx.doi.org/10.1111/hep.2007.37.issue-4.